Risk Vs. Reward Never Gets Old Seeking Alpha Should the results be negative or even mixed, CVM would likely drop to .15, but could soon recover, due to their promising LEAP and H1N1 drugs. The risk seems to outweigh the reward. Additionally, CVM just released an alert that the Independent Data...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment